Conditions: Pyoderma Gangrenosum Crohn's Disease Ulcerative Colitis Inflammatory Bowel Disease
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 2
Healthy volunteers: no

Brief summary:
Subjects must be 18- 75 years old and have a history of both inflammatory bowels disease (Crohn's or ulcerative colitis) and pyoderma gangrenosum.

This is a 6 month open label study of an intravenous (IV) medication. Visits occur every 2 weeks initially, then every 1-2 months later in the study.

Detailed description:

Arms:
arm 1: Single arm open label IV Infliximab given at weeks 1,2,14,22

Interventions: intervention 1: Infliximab
Intervention descriptions: intervention 1: IV drug given at weeks 1,2,14,22

Protocol document: